Afalaza pills №100

Composition

Active substances:

Antibodies to endothelial NO-synthase, affinity-purified - 0.006 g *
Antibodies to prostate-specific antigen, affinity-purified - 0.006 g. *

lactose monohydrate, microcrystalline cellulose, Magnesium stearate.
* applied to lactose in the form of a mixture of three active aqueous-alcoholic dilutions of the substance, diluted in 10012, 10030, 100200 times, respectively

Mechanism of action

Prostate hyperplasia is a benign treatment agent.

Indications and usage

Benign prostatic hyperplasia of stage I and II.
In the complex treatment of acute and chronic prostatitis - as an anti-inflammatory and analgesic.
Dysuric disorders (frequent urge to urinate, difficulty urinating, pain and discomfort in the perineal area).
Erectile dysfunction (erectile dysfunction) of various origin.
Vegetative menopausal disorders in men (weakness, fatigue, decreased physical activity, decreased libido, etc.).
Combined therapy used before and after surgery on the prostate gland.

Contraindications

Increased individual sensitivity to the components of the drug.

Adverse reactions

When using the drug for the indicated indications and in the indicated dosages, no side effects were revealed.

Drug interactions

Cases of incompatibility with other drugs have not yet been registered.

Dosage and administration

Inside At one time - 2 pills (to keep in the mouth until completely dissolved - not during the meal). The drug is taken twice a day, in the evening and in the morning. The recommended duration of the drug is 16 weeks.
With severe pain syndrome and dysuric disorders in the first 2-3 weeks of therapy, the drug is indicated up to 4 times a day.
If necessary, on the recommendation of a doctor, it is possible to repeat the course of treatment in 1-4 months.

Overdosage

In case of accidental overdose, dyspeptic symptoms are possible due to the fillers in the preparation.

Special notes

The preparation contains lactose, and therefore it is not recommended to prescribe it to patients with congenital galactosemia, glucose or malabsorption malabsorption syndrome, or with congenital lactase deficiency. Afalaza does not affect the ability to drive vehicles and other potentially dangerous machinery.